position in vertex? as a stock, not a bond holding? i like the slight aggressiveness with stock holdings but adding a risky pharma to a high-yield bond fund looks dumb when that pharma pick turns out to be sh**. what makes these guys think they can pick a pharma stock and make useful analysis of FDA rulings, potential competition, etc. tahyx is great, but come on management! vertex? dumb.